0082N0 Stock Chart & Stats
₩10750.00
₩1,510.00(16.34%)
―
--
Day’s Range― - ―
52-Week Range₩9,170.00 - ₩70,000.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)75.66K
Market Cap
₩142.60B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.22
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding13,265,080
10 Day Avg. Volume52,608
30 Day Avg. Volume75,662
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)₩4.92B
0082N0 FAQ
What was Kanaph Therapeutics Inc.’s price range in the past 12 months?
Kanaph Therapeutics Inc. lowest stock price was ₩9170.00 and its highest was ₩70000.00 in the past 12 months.
What is Kanaph Therapeutics Inc.’s market cap?
Kanaph Therapeutics Inc.’s market cap is ₩142.60B.
When is Kanaph Therapeutics Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Kanaph Therapeutics Inc.’s earnings last quarter?
Kanaph Therapeutics Inc. released its earnings results on May 13, 2026. The company reported -₩406.486 earnings per share for the quarter, missing the consensus estimate of N/A by -₩406.486.
Is Kanaph Therapeutics Inc. overvalued?
According to Wall Street analysts Kanaph Therapeutics Inc.’s price is currently Undervalued.
Does Kanaph Therapeutics Inc. pay dividends?
Kanaph Therapeutics Inc. does not currently pay dividends.
What is Kanaph Therapeutics Inc.’s EPS estimate?
Kanaph Therapeutics Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kanaph Therapeutics Inc. have?
Kanaph Therapeutics Inc. has 13,265,080 shares outstanding.
What happened to Kanaph Therapeutics Inc.’s price movement after its last earnings report?
Kanaph Therapeutics Inc. reported an EPS of -₩406.486 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.856%.
Which hedge fund is a major shareholder of Kanaph Therapeutics Inc.?
Currently, no hedge funds are holding shares in KR:0082N0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Bioneer Corporation
―
Anterogen Co., Ltd.
―
Jeil Pharmaceutical Co. Ltd.
―
Prestige Biologics Co., Ltd.
―
Y-Biologics Inc.
―